[1]
A. Yüksel, “Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD)”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 43, no. 1, p. 17022, Mar. 2026, doi: 10.36141/svdld.2026.17022.